TickerFacts.

Nanoviricides, Inc. (NNVC): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2014-06-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.20M
As of 2026-06-30
-16.1%
3-year compound annual growth
-21.5%
10-year compound annual growth
$20.49M2012-06-30: $1.78M2013-06-30: $8.40M2014-06-30: $20.49M2015-06-30: $12.40M2016-06-30: $13.59M2017-06-30: $6.68M2018-06-30: $881.9K2022-06-30: $412.8K2023-06-30: $2.03M2024-06-30: $1.36M2025-06-30: $1.30M2026-06-30: $1.20M$1.20M
2012-06-30 Total Liabilities (USD) 2026-06-30
Period endedTotal LiabilitiesChange YoYSource filing
2026-06-30$1.20M-7.7%2026-09-28, Balance as of period end
2025-06-30$1.30M-4.3%2025-09-29, Balance as of period end
2024-06-30$1.36M-33.2%2024-09-27, Balance as of period end
2023-06-30$2.03M+392.7%2024-09-27, Balance as of period end
2022-06-30$412.8Kn/a2023-10-13, Balance as of period end
No annual figure between 2018-06-30 and 2022-06-30.
2018-06-30$881.9K-86.8%2018-10-12, Balance as of period end
2017-06-30$6.68M-50.8%2018-10-12, Balance as of period end
2016-06-30$13.59M+9.5%2017-09-28, Balance as of period end
2015-06-30$12.40M-39.5%2016-09-16, Balance as of period end
2014-06-30$20.49Mn/c2015-09-14, Balance as of period end
2013-06-30$8.40M+371.9%2015-02-23, Balance as of period end
2012-06-30$1.78Mn/a2013-10-08, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Nanoviricides, Inc. (NNVC)2026-06-30$1.20M-7.7%
Bristol Myers Squibb Co (BMY)2025-12-31$71.53B-6.1%
TherapeuticsMD, Inc. (TXMD)2025-12-31$10.78M-5.9%
Pfizer Inc (PFE)2025-12-31$121.39B-2.8%
Johnson & Johnson (JNJ)2025-12-28$117.67B+8.3%
Nature's Sunshine Products Inc (NATR)2025-12-31$99.59M+24.7%
Provectus Biopharmaceuticals, Inc. (PVCT)2025-12-31$7.00M+0.4%
Lisata Therapeutics, Inc. (LSTA)2025-12-31$3.14M-44.7%
Heron Therapeutics, Inc. (HRTX)2025-12-31$241.54M-9.5%

Compare NNVC, BMY, TXMD, PFE side by side · Screen every company in Pharmaceutical Preparations ↗